Transaction in Own Shares

Summary by AI ^BETAClose X

Fevertree Drinks plc has announced the purchase of 191,481 ordinary shares between May 11th and May 15th, 2026, as part of its share buyback program. The volume-weighted average price for these purchases ranged from 778.2958 pence to 805.5000 pence per share, with the lowest price recorded at 764.0000 pence and the highest at 809.5000 pence. The company intends to cancel these repurchased shares.

Disclaimer*

Fevertree Drinks PLC

19 May 2026

19^th May 2026

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Transaction in Own Shares

Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has, in accordance with the authority granted by shareholders at its 2025 Annual General Meeting held on 5^th June, purchased the following number of ordinary shares of £0.0025 each in the Company (the "Ordinary Shares") through the Company's broker, Investec Bank plc ("Investec") in the period from 11^th May to 15^th May 2026.

Date	Venue	Volume-weighted average price (p)	Aggregated volume	Lowest price per share (p)	Highest price per share (p)
11 May 2026	XLON	801.6729	17,992	791.5000	809.5000
11 May 2026	AIMX	805.5000	18,000	805.5000	805.5000
12 May 2026	XLON	780.6957	29,218	770.0000	800.0000
12 May 2026	AIMX	790.6598	14,368	775.0000	797.5000
13 May 2026	XLON	790.0868	23,559	785.5000	796.5000
13 May 2026	AIMX	793.5000	20,000	793.5000	793.5000
14 May 2026	XLON	797.0241	29,385	790.5000	802.5000
14 May 2026	AIMX	794.0000	15,000	794.0000	794.0000
15 May 2026	XLON	778.2958	28,969	764.0000	787.0000
15 May 2026	AIMX	777.0000	15,000	777.0000	777.0000

The Company intends to cancel the purchased shares.

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual trades made by Investec on behalf of the Company as part of the share buyback programme is attached to this announcement.

http://www.rns-pdf.londonstockexchange.com/rns/7176E_1-2026-5-18.pdf

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

For further information please contact:

Investor queries

Steve Nightingale, Director of Investor Relations I steve.nightingale@fever-tree.com I +44 (0)7951 849564

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END